Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia [6]

Lancet

Volumn 348, Issue 9036, 1996, Pages 1242-1243

  Ben Yosef, R ^a   Or, R ^a   Nagler, A ^a   Slavin, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BACTERIAL INFECTION; BLAST CELL; BREAST CANCER; BREAST SURGERY; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LEUKOCYTE COUNT; LYMPH NODE DISSECTION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RASH; STEM CELL TRANSPLANTATION;

EID: 0029806830     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65517-1     Document Type: Letter

References (3)

1. S Salvin E Naparstek A Nagler Allogeneic cell therapy for relapsed leukemia following bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol 23 1995 1553 1562
2. M Horowitz R Gale P Sondel Graft versus leukemia reactions after bone marrow transplantation. Blood 75 1990 555 562
3. B Ebil H Schwaighhofer D Nachbaur Evidence of graft versus tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer Blood 88 1906 1501 1508